Who Chooses Open-Source Software?
Mark A. Lemleyt & Ziv Shafirtt
Economists and legal scholars have debated the reasons people adopt opensource software, and accordingly whether and to what extent the open-source model
can scale, replacingproprietaryrights as a primary means of production.In this Article,
we use the release by a biotechnology company of similar software under both proprietary and open-source licenses to investigate who uses open-source software and why.
We find that academic users are somewhat more likely to adopt open-source software
than private firms. We find only modest differences in the willingness of open-source
users to modify or improve existing programs. And we find that users of open-source
software often make business decisions that seem indifferent to the norms of opensource distribution. Ourfindings cast some doubt on the penetrationof the open-source
ethos beyond traditionalsoftware markets.

I. BACKGROUND

The traditional theory of intellectual property (IP) is well understood. Creators of intellectual content would have insufficient incentive to create if their works could be cheaply and quickly imitated.
Thus, the law grants legal control over new creations in order to prevent, delay, or raise the cost of imitation and therefore encourage investment in creation.
The rise of open-source software poses an important challenge to
the classic account of the production of intellectual public goods. Instead of using IP rights to optimize monetary benefit, open-source
production relies on IP rights to keep software, and any improvements or additions to it, free and widely accessible. Open-source software is provided to others for free; providers profit, if at all, not by
selling the software or improvements to it but by providing consulting
or other services.
Scholars vigorously debate whether open-source software represents a fundamental new means of collaborative production potentially
extendable to other forms of human endeavor2 or an altruistic fringe
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to the dominant market-based model of production. For economists
in particular, this debate is intimately bound up with questions about
the motivations of those who participate in open-source production. If
the classic theory of IP holds-if people are rational economic actors
who will create only if the expected rewards exceed the costs-then
open-source production is likely to be limited to the creation of relatively low-cost or small-scale products, primarily by those who do it in
their spare time out of altruism or intellectual curiosity or who are
otherwise subsidized (perhaps by a government or university) to create software without being paid for it.4 By contrast, if people are collectively motivated to create by nonfinancial incentives, or if there is a
sustainable market for the provision of services ancillary to opensource products,' the open-source model could conceivably displace
proprietary software and even extend to products other than software,
such as DNA databases.'
The economic literature has made substantial strides in trying to
explain and characterize the free and open software movement. Explanations focus on social norms and ethics that reward contributors in
nonmonetary ways (for example by enhancing reputation in a community),' on the unique characteristics of software as a network good and
the corresponding possibility of monetizing services or ancillary products,8 or on expected benefits from private learning or from reciprocal
3 See Andrew George, Avoiding Tragedy in the Wiki-Commons, 12 Va J L & Tech 1,
In 8-9 (Fall 2007); Ronald J. Mann, Commercializing Open Source Software: Do PropertyRights
Still Matter?, 20 Hary J L & Tech 1, 24-25 (2006); Andrea Bonaccorsi and Cristina Rossi, Altruistic Individuals, Selfish Firms? The Structure of Motivation in Open Source Software, 9 First
Monday 5 (Jan 2004), online at http://firstmonday.org/htbin/cgiwrap/bin/ojs/index.php/fm/article/
view/1113/1033 (visited Oct 18, 2010) (showing that altruism is a motivating factor for individual
programmers); David McGowan, Legal Implications of Open-Source Software, 2001 U Ill L Rev
241,260-62.
4
See Jan Eilhard, Open Source Incorporated*52-55 (unpublished manuscript, Feb 2009),
online at http://ssrn.com/abstract=1360604 (visited Oct 18, 2010).
5 See Michele Boldrin and David K. Levine, Market Structure and Property Rights in
Open Source Industries, 30 Wash U J L & Pol 325, 330-33 (2009); James Bessen, Open Source
Software: Free Provisionof Complex Public Goods, in Jiurgen Bitzer and Philipp J.H. Schrdeder,
eds, The Economics of Open Source Software Development 57,79-80 (Elsevier 2006).
6
See Andrew W. Torrance, Open Source Human Evolution, 30 Wash U J L & Pol 93,
125-28 (2009); Stephen M. Maurer, Arti Rai, and Andrej Sali, Finding Cures for Tropical Diseases: Is Open Source an Answer?, 6 Minn J L, Sci, & Tech 169, 171 (2004).
7
See Josh Lerner and Jean Tirole, Some Simple Economics of Open Source, 52 J Indust
Econ 197, 212-15 (2002); Josh Lerner and Jean Tirole, The Open Source Movement: Key Research Questions, 45 Eur Econ Rev 819, 822-23 (2001); Eric S. Raymond, The Cathedraland the
Bazaar 64-66 (O'Reilly 1999).
8 See Stephen M. Maurer and Suzanne Scotchmer, Open Source Software: The New Intellectual Property Paradigm, in Terrance Hendershott, ed, Economics and Information Systems
285, 290-92 (Elsevier 2006); Mann, 20 Hary J L & Tech at 33-34 (cited in note 3); Robert P.
Merges, A New Dynamism in the Public Domain, 71 U Chi L Rev 183, 192-93 (2004); Yochai
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contribution by others.! It has also emphasized that roughly half of all
open-source contributors are paid for their contribution, usually by
corporate sponsors," though that raises the question of why the corporations are willing to pay that money.
Critical to advancing this debate is understanding who chooses
open-source software and why.
II. OUR STUDY
In this study, we take advantage of a natural experiment in the
provision of software in the bioinformatics industry to test motivations and usage patterns for open-source and proprietary software.
Affymetrix, a company that sells microarrays (branded as
"GeneChips") for use in DNA-based laboratory tests, provides software that enables purchasers to use the chips and analyze the results."
Specifically, Affymetrix and other companies have developed several
algorithms that summarize the chip probe-set results and normalize
the resulting data, allowing users of the Affymetrix GeneChip to analyze and understand the results of the chip probes. They have in turn
implemented these algorithms in a variety of software programs.
Importantly, Affymetrix makes available both open-source and
proprietary versions of the same basic algorithms and software.12
Called "dual licensing" or "versioning," this dual release strategy is

Benkler, Coase's Penguin, or, Linux and The Nature of the Firm, 112 Yale L J 369, 411-12
(2002); McGowan, 2001 U Ill L Rev at 250-53 (cited in note 3).
9 See Karim R. Lakhani and Eric von Hippel, How Open Source Software Works: "Free"
User-to-User Assistance, 32 Rsrch Pol 923, 936-37 (2003) (finding that programmers post answers to open-source questions because they have benefitted from the answers in the past or
expect to in the future).
10 See Eilhard, Open Source Incorporatedat *15, 26-27 (cited in note 4).
11 See Affymetrix, GeneChip-Compatible Software Providers, online at http://www.
(visited
affymetrix.com/estore/partnersprograms/genechip-compatible/genechip-compatible.affx
Oct 19,2010).
12 A full list of both open-source and proprietary algorithms is provided in Appendix A. The
open-source algorithms are released under a variety of different licenses. Bioconductor is released
under version 2 of the GNU Public License (GPL 2), which requires the user to release the source
code for any modifications to others without charge. GNU, General Public License, Version 2,
online at http://www.gnu.org/licenses/gpl-2.0.html (visited Oct 19, 2010). dChip, by contrast, is
released under a looser standard that seems to approach freeware; the source code is made available, and the license says that "if you build a Unix or Linux version, we will appreciate it if you can
share the codes or binaries or be linked from this page." dChip: Introduction and Installation,
online at http://biosunl.harvard.edu/complab/dchip/install.htm (visited Oct 19, 2010). On the bewildering array of open-source and related licenses, see Robert W. Gomulkiewicz, Open Source
License Proliferation:Helpful Diversity or Hopeless Confuision?, 30 Wash U J L & Pol 261, 264-77
(2009). See also Robert W. Gomulkiewicz, Conditions and Covenants in License Contracts: Tales
from a Test of the Artistic License, 17 Tex Intel Prop L J 335, 337-39 (2009).
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increasingly common in the open-source software environment.
Affymetrix provides parallel software in two different versions because it believes that some users will want the low cost of open-source
software, while some private firms will want to improve on the software or add their own proprietary extensions without being subject to
the obligation to release those extensions under an open-source license. This provides a natural test of customer selection of opensource or proprietary software."
To test those usage patterns, we conducted two studies. First, we
reviewed publications from Affymetrix's "Scientific Publications"
page for the period from 2007 to 2008." In all, we found 178 publications that make reference to algorithms of software for interpreting
data from the Affymetrix GeneChip. We collected data on the entity
status of each author, and on the algorithm and the software those
authors used. When users write papers disclosing results made using
the GeneChip, they almost always cite the software they relied on to
generate those results." As a result, we can learn about usage patterns
by observing publication patterns.
Those usage patterns will be biased, however, because they represent not all users of Affymetrix GeneChips but only those who publish their results. That group is likely to include disproportionate
numbers of academic and nonprofit users. And indeed we find in the
next Part that most publishers are academics. To ensure that private
firm users are represented, we oversampled commercial users in the
publication search. Publication also cannot account for intensity of
use, though there should be some relationship between the two: those
who use the chip to make a publishable discovery are likely to be
13 See Stefano Comino and Fabio M. Manenti, Dual Licensing in Open Source Software
Markets *3-4 (unpublished manuscript, Jan 2010), online at http://ssrn.com/abstract=985529
(visited Oct 19, 2010); Robert W. Gomulkiewicz, EntrepreneurialOpen Source Software Hackers: MySQL and Its DualLicensing, 9 Computer L Rev & Tech J 203, 208-11 (2004).
14 The test is not perfect, because the algorithms and software implementing those algorithms are not identical. First, we note that the algorithms and the software are not necessarily
independent variables. For example, MAS 5.0 does not run the RMA algorithm, and
GeneSpring does not run the MAS algorithm. As a result, some users might have chosen their
software based on the algorithms rather than the open-source or proprietary issues. Second,
since we study Affymetrix microarrays, our study sample is naturally biased toward users who
have a greater propensity to choose the Affymetrix GCOS or MAS 5.0 software than do people
buying Illumina microarrays. Notwithstanding these limitations, the programs are used for the
same purpose, written by the same people, and have significant similarities.
15 For a full discussion of how those sources were selected, see Appendix B.
16 This is confirmed by survey data: 95.4 percent of academic users, 90.9 percent of other
nonprofit users, and 80 percent of private firms who wrote a paper using the results cited the
software in that paper. Overall, 250 of 270 survey respondents who published papers, or
92.6 percent, cited the software by name in the paper. For the original survey question, see Appendix C, question 14.
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more intensive users than those who do not, all other things being
equal. Still, this is a limitation of the publication data.
To explore the motivations of users and the uses they make of
the software, we supplement the literature search with a survey of
users of the Affymetrix GeneChip. We sent out surveys to a wide
range of individuals who have used the Affymetrix software and received 437 complete and usable responses." Of the 437 respondents,
305 (or 69.8 percent) were academics, 52 (or 11.9 percent) were nonprofit entities, and 80 (or 18.3 percent) were at private firms. The results indicate a predominance of academic users, but not surprisingly
include more private firms than did the publication search.
III. RESULTS
A. Publication Data
For each published article, we studied the nature of the authors
(academic, nonprofit, commercial, or mixed); if commercial, the industry (biotechnology or pharmaceuticals) in which the authors
worked; whether the authors were domestic or foreign; and whether
they used commercial or open-source software. We excluded from
consideration review articles or meta-analyses in which the authors
were not themselves running the experiments in which the data were
collected, as well as articles that did not specify the software used. The
summary results are presented in Table 1.

17 This represents a response rate below 50 percent, but given that the survey was sent by
email and without a follow-up, that rate is not abnormally low.
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TABLE 1. DESCRIPTIVE STATISTICS FOR PUBLICATIONS

Category

Number

Total papers
Academic papers
Nonprofit papers (including government)
Commercial papers
Commercial biotech
Commercial pharma
Joint academic-commercial papers
Papers by US authors
Papers by foreign authors
Open-source algorithms/software
Proprietary algorithms/software

178
110
11
55
14
41
*
8
116
62
35
148

* When there were joint papers, we included them in either the commercial or academic
category, but not both. We made this assessment based on who the lead author was and
which side had the greater number of authors. Of the joint papers, six were primarily by
academic authors and two were primarily commercial.
** As with joint authors, we treated papers as primarily either US or foreign
in authorship.

In Table 2, we explore how different actors vary in their use of
open-source and proprietary software.
TABLE 2. USAGE OF OPEN-SOURCE SOFTWARE
BY AUTHOR CHARACTERISTICS
Author Category
Academic papers
Nonprofit papers
Commercial papers
Commercial biotech
Commercial pharma
Joint academiccommercial papers
US authors
Foreign authors

Proprietary
Cites*

Open-Source
Cites

85 (77%)
9(82%)
54 (96%)
13 (93%)
41 (100%)
7 (88%)

31 (28%)
2(18%)
2 (4%)
1 (7%)
1 (2%)
2 (25%)

106(91%)
52 (84%)

24(22%)
13 (21%)

* Some authors cited both open-source and proprietary software, so the percentages
may exceed 100 percent.

The difference between academic and commercial users of opensource software is dramatic. The results are depicted in Figure 1.

Who Chooses Open-Source Software?

2011]

145

FIGURE 1. SOFTWARE USAGE OF ACADEMIC VERSUS
COMMERCIAL USERS
73.0%

.

96.0%

Academic Users

Commercial Users

4.0%

27.0%
[

Proprietary Software Cites

[] Open-Source

Software Cites

The publication data suggest that academic users are far more
likely to use open-source software than commercial entities; only a
very small percentage of commercial users made use of open-source
software, and half of those did so in the course of academiccommercial collaborations.
One possible explanation for this result is that commercial users
want to release products using or incorporating the GeneChip software
and charge for those products, something open-source licenses would
restrict." We investigate that possibility in the next Part. Relatedly,
commercial users may be worried about the risk of legal entanglement
that comes with open-source software even if they are not now planning to release a product that incorporates that software. Another possibility is that commercial users expect proprietary software to be superior, with additional features or better usability, and are more willing
than academic users to pay for that additional functionality.
B.

Survey Data

With the assistance of Affymetrix, we surveyed users of Affymetrix GeneChips. We asked survey respondents a variety of questions,
including which algorithms and which software they used, whether
they were aware of other software, why they chose the version they did,
whether they provided bug reports or fixes, whether they modified or
improved the software, whether they released those modifications and
18 Exactly what form this restriction takes is a complicated question. A few open-source
licenses, such as the BSD license, do not prevent licensees from charging for products. The GPL
and related licenses, strictly speaking, allow the licensee to charge for products made using the
license, but they also require that the code be made available for free, which makes the collection of revenue more difficult.

The University of Chicago Law Review

146

[78:139

if so to whom, and whether they published their results." We can
sort these results on the answer to any previous question; in much of
what follows, we distinguish between those who used open-source
software and algorithms and those who used proprietary software
and algorithms.
We begin by replicating the analysis from the publication survey,
measuring academic, nonprofit, and commercial users and users of opensource or proprietary software. The results appear in Tables 3 and 4.
TABLE 3. DESCRIPTIVE STATISTICS FOR SURVEY DATA

Category

Number

Total respondents
Academic respondents
Nonprofit respondents
Commercial respondents
Respondents using open-source
algorithms/software
Respondents using proprietary
algorithms/software

442*
305 (68.1%)
52 (11.7%)
80 (17.9%)
251 (57.4%)

369 (84.4%)

Five respondents did not fit into one of the listed categories.

TABLE

4. USAGE OF OPEN-SOURCE SOFTWARE BY
AUTHOR CHARACTERISTICS

Proprietary

Open-Source

Author Category

Uses

Uses

Academic users
Nonprofit users
Commercial users

245 (68.6%)
43 (12.0%)
62 (17.4%)

174 (71%)
25 (10.2%)

43 (17.6%)

N = 357; 12 did not answer the question. Of the 357, 7 (2.0 percent) were independent
*
or reported no affiliation.
** N = 245; 6 did not answer the question. Of the 245, 3 (1.2 percent) were independent or
reported no affiliation.
19 The complete list of questions is attached as Appendix C.
20 We included Bioconductor and dChip in the open-source category and Stratagene ArrayAssist, Stratagene ArrayAssist Lite, Rosetta Resolver, GeneChip Operating System
(GCOS), GeneSpring, Affymetrix Power Tools, Affymetrix Expression Console, Microarray
Suite (MAS), and Spotfire in the proprietary category. There was also a survey option of "Other," in which the vast majority of people listed other less well-known proprietary softwarethese answers were included in the "proprietary" category.
We also had many users who used both open-source and proprietary software and algorithms. As a general matter, we have included joint users in both the open-source and proprietary software categories, but at various points we have separated them into their own group. We
note that in Table 5.
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Curiously, the data here show no similar distinction between academic and commercial users. Indeed, commercial users made up the
same percentage of users of both open-source and proprietary software. And we were unable to reject the hypothesis that each type of
user was equally likely to use open-source or proprietary software.2
We do find modest differences in the stated reasons why people
employed particular programs. Those who used proprietary software
gave the following answers:
Why did you choose the version you did? [check all that apply]

Answer Options
It was compatible with/used the desired
processing algorithm (such as RMA,
GC-RMA, MAS 5.0)
It was cheaper
It gave me greater freedom to modify
the software
It was more reliable
It was more convenient
It had better support
My institution already had a license to it
Other
If "Other," please explain in your own
words why you chose the version you did:

Response
Frequency

Response
Count

67.4%

225

35.0%
29.6%

117
99

30.8%
37.7%
22.5%
30.2%
9.6%

103
126
75
101
32
41

Answered question
Skipped question

21

The statistical tests are available from the authors upon request.

334
35
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By contrast, those who used open-source software gave the following answers:
Why did you choose the version you did? [check all that apply]

Answer Options
It was compatible with/used the desired
processing algorithm (such as RMA,
GC-RMA, MAS 5.0)
It was cheaper
It gave me greater freedom to modify
the software
It was more reliable
It was more convenient
It had better support
My institution already had a license to it
Other
If "Other," please explain in your own
words why you chose the version you did:
Answered question
Skipped question

Response Response
Frequency Count
74.6%

176

47.5%
42.4%

112
100

31.8%
34.7%
21.6%
23.7%
7.2%

75
82
51
56
17
24
236
15

There are some differences here that line up with expectationsusers of open-source software put more emphasis on cost (47.5 versus
35 percent) and on ability to modify the software (42.4 versus
29.6 percent), for instance. But the overall differences are surprisingly
modest. Indeed, differences between respondents' answers to the cost
and ability to modify questions are the only ones that are statistically
significant at a 99 percent confidence level.'
We also find modest differences in the use people make of the different types of software. For example, users of open-source software
were marginally more likely to send fixes or bug reports back to the
software developers. Among open-source users, 42.3 percent provided
bug reports, compared with 37.8 percent of proprietary software users;
23.5 percent of open-source users improved the software, compared
with 19.1 percent of proprietary users. Fifty percent of the open-source
users who modified the software released that software to others, compared with 45.6 percent of those who modified proprietary software.

22

With only 90 percent confidence, we can say that users preferred open-source software

because it was compatible with what they already used, and proprietary software if their firm
already had a license to it.
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One reason the data appear so noisy may be that these measures
include a significant number of users who employed both open-source
and proprietary GeneChip software at different times. This is the most
logical way to explain the result that 35 percent of users of proprietary
software stated "lower cost" as a reason for choosing the software they
did, for example.' As a result, we also report a restricted sample limited
to those who used only open-source or only proprietary software.'
The results of the restricted sample are more consistent with our
expectations. We report the descriptive statistics in Table 5. We emphasize, however, that the restricted sample is smaller and that none
of these differences is statistically significant.
TABLE 5. USAGE OF SOLELY OPEN-SOURCE OR PROPRIETARY
SOFTWARE BY AUTHOR CHARACTERISTICS

Author Category

Solely Proprietary
Uses*

Solely OpenSource Uses"

Academic users
Nonprofit users
Commercial users

114 (64.8%)
22 (12.5%)
34 (19.3%)

33 (73.3%)
4 (8.9%)
8 (17.8%)

* N = 185; 9 did not answer the question. Of the 185, 6 (3.2 percent) were independent or reported no
affiliation.

* N = 47; 2 did not answer the question.

The differences between the reasons users offer for choosing
solely open-source or proprietary software, by contrast, are more pronounced in the restricted sample. Respondents who used only opensource software gave the following answers:

23 It is also possible that some users considered proprietary software cheap because their
institution already owned a license to it, but that should at most equalize the cost vis-A-vis opensource software.
24 This restricted sample will of necessity exclude those who switched from proprietary to
open-source software (or, more problematically, from open-source to proprietary software)
during the time of the study. See Greg R. Vetter, Commercial Free and Open Source Software:
Knowledge Production, Hybrid Appropriability, and Patents, 77 Fordham L Rev 2087, 2129-31
(2009) (discussing examples of companies that switch modes).
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Why did you choose the version you did? [check all that apply]

Answer Options

Response
Frequency

It was compatible with/used the desired
processing algorithm (such as RMA,
GC-RMA, MAS 5.0)
It was cheaper
It gave me greater freedom to modify
the software
It was more reliable
It was more convenient
It had better support
My institution already had a license to it
Other
If "Other," please explain in your own
words why you chose the version you did:

Response
Count

64.9%

24

64.9%
54.1%

24
20

27.0%
18.9%
16.2%
2.7%
2.7%

10
7
6
1
1
2

Answered question
Skipped question

37
10

By contrast, those who used only proprietary software gave the
following answers:
Why did you choose the version you did? [check all that apply]

Answer Options

Response
Frequency

It was compatible with/used the desired
53.9%
processing algorithm (such as RMA,
GC-RMA, MAS 5.0)
It was cheaper
21.4%
It gave me greater freedom to modify the 16.9%
software
It was more reliable
28.6%
It was more convenient
37.7%
It had better support
23.4%
My institution already had a license to it
32.5%
Other
16.2%
If "Other," please explain in your own
words why you chose the version you did:
Answered question
Skipped question

Response
Count
83
33
26
44
58
36
50
25
30
154
31
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Both sets in the restricted sample emphasized compatibility as
a strong factor in software choice, suggesting a fair degree of path
dependence driving the results. Open-source software users were
more likely to emphasize the lower cost (64.9 versus 21.4 percent) and
freedom to modify their software (54.1 versus 16.9 percent); proprietary software users were more likely to point to an existing institutional license (32.5 versus 2.7 percent) and the convenience of the
software (37.7 versus 18.9 percent).'
We also find modest differences in the use people make of the
different types of software in our restricted sample. We report those
differences in Table 6.
TABLE 6. BUG REPORTING AND SOFTWARE IMPROVEMENT
DIFFERENCES BETWEEN OPEN-SOURCE
AND PROPRIETARY USERS

Type of Usage
Reported bugs or sent fixes
Improved the software
Released modified software
to others

Proprietary
Users

Open-Source
Users

32.8%
16.4%
48.3%

35.6%
22.2%
60.0%

Differences between open-source and proprietary users are not statistically significant in any of the
categories.

Users of open-source software were not appreciably more likely
to send fixes or bug reports back to the software developers35.6 percent of open-source users provided bug reports, compared
with 32.8 percent among proprietary software users; 22.2 percent of
open-source users improved the software, compared with 16.4 percent
of proprietary users. Sixty percent of the open-source users who modified the software released that software to others, compared with
48.3 percent of those who modified proprietary software. As with the
unrestricted sample, the differences are surprisingly modest, and none
is statistically significant.
This is a curious result. Under the general terms of open-source
software licenses, those who modify or contribute new software that
they sell or distribute must make their new or modified code available
to others. There might be an argument that open-source rules do not
require that the source code be publicly distributed at all but simply
25 The "cheaper," "freedom to modify," and "license" answers are statistically significant
at the 99 percent confidence level; the "convenience" answer is significant at the 95 percent
confidence level.
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provided on request.6 But even so, we find that most open-source users who released improved software did so only to their own customers (67.9 percent in the unrestricted sample; 83.3 percent in the restricted sample), despite the presumed obligation to make the code
available to anyone who wanted it. Those who did release the software improvements usually did so under their own brand names78.6 percent for open-source users (100 percent in the restricted sample) and 72.4 percent for proprietary software users (61.5 percent in
the restricted sample).
Interestingly, the rationale that drove Affymetrix to release parallel
programs in both open-source and proprietary formats-the belief that
customers would want proprietary software because they hoped to improve on it and sell the improvement-does not appear to be borne out
in the data. Some users of both open-source and proprietary software
modified the software and released their modifications to the public
as products. Users of open-source software were slightly more likely
to modify the program than users of proprietary software. They were
marginally more likely to release that software to the public, and marginally more likely to brand that improved software with their own
mark. Again, however, we note that these differences are modest and
not statistically significant.
IV. IMPLICATIONS

What stand out in these results are not the differences between
open-source and proprietary software users but the similarities. Users
of the probe-set summarization and normalization software seem
largely indifferent to whether the software they use is open-source or
proprietary. They often use multiple programs and algorithms, some
of which are open source and some of which are proprietary. That sort
of mixing is a big worry for open-source lawyers; indeed, there are
companies designed to audit software code to make sure there is no
inappropriate mixing.' Mixing is relevant primarily for those who
change or improve code, not for passive users. But we find that roughly a quarter of users, including many users of both open-source and
proprietary software, do in fact improve the software and release their

26

The GPL 2 provides that "[y]ou must make sure that [recipients], too, receive or can get

the source code." GNU, General Public License, Version 2 (cited in note 12). This could be

satisfied by a distribution on request. And the BSD license does not impose that constraint.
27
See, for example, Black Duck Software, Multi-source Development with Open Source
Software, online at http://www.blackducksoftware.com/multisourcedevelopment (visited Oct 20,
2010); Gomulkiewicz, 9 Computer L Rev & Tech J at 207, 210-11 (cited in note 13).
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improvements to others.' Curiously, even these improvers seem largely indifferent to the open-source-proprietary line, to the extent that
many of them appear to be ignoring the fundamental constraint of
open-source software-that you release your improvements to everyone. In fact, it is not clear that they are even aware of the limits on
behavior that open-source licenses impose.
This is a small study in a single industry, one in which the users
are not primarily computer programmers. Further research may reveal whether our conclusion is merely an artifact of our study universe, whether similar behavior exists in more traditional open-source
software contexts, or whether the result is driven by the fact that users
outside the central open-source community have not fully internalized
the norms of open-source software. More study is required.'
But if our results are generalizable, they have a broader implication: to bring to bear the "law in action" literature to the opensource-proprietary divide. While the law-and the intent of the opensource movement-draws a sharp distinction between open-source
and proprietary software, placing them effectively in different worlds,
users of the software in bioinformatics appear to observe no such
sharp distinction. They appear to employ a mix of open-source and
proprietary software tools chosen for a variety of reasons, not merely
or even primarily for their openness or appropriability. And they
seem to use those software tools as they will-and not as the niceties
of open-source contracts would suggest. Law may matter to makers of
open-source software, but it does not appear to affect the behavior of
software users.

28 Other studies have found even higher rates of hybrid software use. See The 451 Group,
Executive Overview: Open Source Is Not a Business Model: How Vendors Generate Revenue
from Open Source Software *1 (Oct 2008), online at http://www.the451group.com/reports/
executivesummary.php?id=694 (visited Oct 31, 2010) (finding that 50 percent of open-source
software vendors use a hybrid model); Eilhard, Open Source Incorporatedat *26-27 (cited in
note 4) (finding that nearly half of open-source programmers are paid for their work).
29 Others have surveyed computer programmers in more traditional software industries.
See, for example, Sujoy Chakravarty, Eman Haruvy, and Fang Wu, The Link between Incentives
and Product Performance in Open Source Development: An Empirical Investigation, 9 Global
Bus & Econ Rev 151, 159-60 (2007); Guido Hertel, Sven Niedner, and Stefanie Herrmann,
Motivation of Software Developers in Open Source Projects: An Internet-Based Survey of Contributors to the Linux Kernel, 32 Rsrch Pol 1159, 1166 (2003); Sharon Belenzon and Mark
Schankerman, Motivation and Sorting in Open Source Software Innovation *21-24 (unpublished
manuscript, Oct 2008), online at http://ssrn.com/abstract=1401776 (visited Oct 20, 2010). And
one study measured open-source adoption in hospitals. See Gilberto Munoz-Cornejo, Carolyn
B. Seaman, and A. Giine§ Koru, An EmpiricalInvestigation into the Adoption of Open Source
Software in Hospitals,3 Intl J Healthcare Info Sys & Informatics 16, 26 (July-Sept 2008).
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This in turn inclines us to a policy of legal neutrality with regard
to open-source and proprietary software.' Open-source software is
not "better" than proprietary software, nor the reverse. Users wantand should have-the freedom to choose the right software for their
particular purposes. But legal scholars need to understand that those
users are often less concerned with the niceties of software licenses
than with using whatever tool seems best suited to the job at hand.
William Gibson famously said that "the street finds its own uses for
things."" The same, it seems, can be said of technology licenses.

30 See generally Robert W. Hahn, ed, Government Policy toward Open Source Software
(Brookings 2002).
31 William Gibson, Burning Chrome, in William Frucht, ed, Imaginary Numbers: An Anthology of Marvelous Mathematical Stories, Diversions,Poems, and Musings 195, 212 (Wiley 1999).
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APPENDIX A. LIST OF PROGRAMS AND ALGORITHMS STUDIED
Software

Algorithms
Proprietary

Open Source

MAS 5.0

Microarray Analysis
Suite 5.0 (MAS 5.0)

Bioconductor

RMA/GC-RMA

GeneChip Operating

dChip

System

(GCOS)

PLIER

GeneSpring

Rosetta Resolver

Affymetrix Power
Tools
Affymetrix Expression
Console
Stratagene

ArrayAssist

Stratagene ArrayAssist
Lite
Rosetta Resolver
Spotfire

Other
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APPENDIX B. METHODOLOGY FOR IDENTIFYING
RELEVANT PUBLICATIONS
We analyzed scientific publications to identify the software used
to conduct primary probe-set summarization on Affymetrix Expression Analysis GeneChips. Probe-set summarization refers to the step
of calculating raw expression data from the scanned image of a microarray. A publication was said to have used a particular software package if it was clear that probe-set summarization was being performed
by the software in question. All other data-analysis steps such as normalization were not considered in deciding which software was used.
The following information was captured for each of the publications:
* Year of publication
* Article name
* Journal name
* Number of authors cited
* Number of different departments and institutions cited
* Primary location of the authors
* Whether the publication was from an academic source, an
NGO, a commercial company, or a combination
* If the publication was from a company, then which industry
that company is in (either pharma or biotech)
* Whether the software cited was proprietary or open source
* The name of the company releasing the software
* The name of the particular software
A.

Academic Publications

Academic publications were randomly chosen in the following
fashion: As of the time we collected the data in 2009, the complete list
of publications that cite Affymetrix are listed on the Affymetrix website, by year, under the "Scientific Publications" page. Publications
are displayed in groups of nine for any particular year.
Using the random number generator from www.random.org, a
random number from one through nine was produced, which would
correspond to a publication in the group of nine, with one denoting
the publication on top, and nine denoting the publication on the bottom. There were 3,622 total publications in 2007, on a total of 363 different pages displaying groups of nine publications for each page.' At

32
For a complete list, see Affymetrix, Results, online at http://www.affymetrix.comlestore/
publications/pub-query-result.affx?year=2007 (visited Jan 16,2011).
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first an article from each page was chosen, but by page 50, the selection switched to choosing articles only from odd-numbered pages.
In total, we analyzed 203 academic publications. Of these, 121
proved useable for analysis. The rest were left out of the analysis because they:
* were not accessible;
* did not explicitly specify the software they were using to get
probe-set summarization data;
* were review articles or were meta-analyses of others' data, rather than reports of primary use of GeneChips; or
* were not using Affymetrix "Expression Analysis Arrays."
B.

Commercial Publications

We also analyzed publications from commercial companies. For
commercial publications, we obtained a list of all of the scientific publications that cited Affymetrix in 2007 and 2008 from Martha Manion,
head librarian of Affymetrix. This list denotes which publications are
from commercial entities. As a result, we collected all publications by
commercial entities, ensuring that there was not a selection bias in
choosing the commercial publications. In total, we analyzed 110 publications; of these, 55 proved usable for analysis. We analyzed only publications by authors solely from commercial companies; no academiccommercial combinations were analyzed in this particular round of
analysis. The exclusion criteria used for academic publications also
applied here.
A full list of publications studied is available from the authors
upon request.
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APPENDIX C. LIST OF SURVEY QUESTIONS
1. Do you use software algorithms to summarize the probe set and/or normalize raw expression data from Affymetrix GeneChips? These are the
steps in GeneChip analysis that turn raw intensity data (.CEL files) into
expression signal values (e.g., .CHP files) that can be compared from microarray to microarray for further analysis.
Answer Options
Yes
No

Response Frequency

Response Count

2. Are you the person within your organization who decided which algorithm and software to use to summarize and/or normalize raw expression
data?
Response
Response
Count
Frequency
Answer Options
Yes
No
If "No," please tell us who within your organization made that decision (contact information is most appreciated)

3. Which of the following algorithms have you used for probe-set summarization or normalization of Affymetrix GeneChip data? [check all that apply]
Answer Options
Microarray Analysis Suite (MAS 5.0 or
MAS 4.0)

RMA/GC RMA
PLIER

Rosetta Resolver
None
I don't know
Other

If "Other," please list the algorithms here

Response
Frequency

Response
Count
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4. Which of the following software programs have you used for probe-set
summarization or normalization of Affymetrix GeneChip data? [check all
that apply]
Response
Response
Count
Frequency
Answer Options
dChip

Bioconductor

Stratagene ArrayAssist
Stratagene ArrayAssist Lite
Rosetta Resolver

GeneChip Operating System (GCOS)
GeneSpring

Affymetrix Power Tools
Affymetrix Expression Console
Microarray Suite
Spotfire

I don't know

None [if you answered "none" to both questions 3 and 4, please skip to the end of the
survey]
Other

If "Other," please list the software programs
here
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5. What do you use the software for? [If different software is used for different steps, please choose the appropriate package used most often in the
right-most column]
Check "Yes" if you use software cited in Question 4 for this function
IYes
Probe-set
summarization
only
Normalization
__

of data only

Both probe-set
summarization
and normalization

Background
subtraction
Plotting and
analysis

Further downstream analysis
(clustering, fold
change analysis,

etc.)

Other
I don't

know

1
_______
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Other software used for this particularfunction
ci

0

U
00

0
'A)

.

C0
)

4

Apnse

only

U

Cu

u4

4

0

P4

0

0

0

)

0

4u

of dat

0

CA

-

4

U

4)

< 0

0u

El)

Probe-set summarization only
Normalization
of data only
Both probe-set
summarization
and normalization
Background
subtraction
Plotting and
analysis
Further downstream analysis
(clustering, fold
change analysis,
etc.)

Other
I don't know
6. Were you aware of the existence of different software programs that
served these purposes?
Response Count
Response Frequency
Answer Options
Yes
No
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7. Why did you choose the version you did? [check all t at apply]
Response
Response
Count
Frequency
Answer Options
It was compatible with/used the desired processing algorithm (such as
RMA, GC-RMA, MAS 5.0)

It was cheaper
It gave me greater freedom to modify
the software
It was more reliable
It was more convenient
It had better support

My institution already had a license to
it
Other

If "Other," please explain in your own
words why you chose the version you
did:

8. Have you provided reports of bugs or other problems with summarization or normalization software since you began using it?
Response
Response
Count
Frequency
Answer Options
Yes
No
9. Have you modified or improved summarization or normalization
software since you began using it?
Response
Response
Count
Frequency
Answer Options
Yes
No

If you answered "Yes," please briefly
describe how you modified it:

10. If so, did you release that modified version to others outside your
organization?
Response Count
Response Frequency
Answer Options
Yes
No

I
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11. If so, did you release the modified version under your own brand
name, or under the original publisher's brand name?
Answer Options
Our own
Original publisher

Response Frequency

Response Count

12. Who did you market, sell, or give the modified version to?
Response Count
Response Frequency
Answer Options
Our existing clients or
partners only

Anyone who wanted it
13. Have you published results based on research you did using microarray analysis software?
Response Frequency

Answer Options
Yes
No

Response Count

14. If so, did you cite the software by name?
Response Frequency

Answer Options
Yes
No

Response Count

15. Are you at an academic research institution or a for-profit company?
Response Frequency

Answer Options
Academic
Other
Private

institution
nonprofit

entity

company

Independent/no affiliation

Response Count
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16. Which role or roles best define your usage of Affymetrix GeneChips?
Response Frequency Response Count
Answer Options
I am the primary user of the
chip, seeing the work
through from when the
GeneChip is first used in an
experiment to when it is
analyzed

I use the GeneChip in my
experiments, but outsource
the analysis of it to a third
party (ex. a core facility)

I conduct the GeneChip
analysis for other people's
experiments (ex. worker at a
core facility)

I don't use GeneChips myself; I extract GeneChip
data from other sources
(such as the Gene Expression Omnibus) and analyze
that
I utilize microarray data
and/or microarray analysis
programs to develop my
own software tools, which I
then market to outside parties

I utilize microarray data
and/or microarray analysis
programs to develop my
own software tools, which I
then release under an open
source license

I utilize microarray data
and/or microarray analysis
programs to develop my
own software tools, which I
then use only internally

I

I have no association with
GeneChips or their data
17. If you would like to be entered into a drawing for an iPod Touch,
then please enter your information below. All identifying information
entered will be kept anonymous and separate from the survey responses.
Response Count
Response Frequency
Answer Options
Name
Email
Phone Number

